We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$84.1M
AUM Growth
+$10.1M
Cap. Flow
+$2.92M
Cap. Flow %
3.47%
Top 10 Hldgs %
25.91%
Holding
112
New
9
Increased
47
Reduced
42
Closed
2

Top Sells

Rank Stock Value
1
SNV
Synovus
SNV
+$338K
2
LLY icon
Eli Lilly
LLY
+$330K
3
CELG
Celgene Corp
CELG
+$318K
4
X
US Steel
X
+$314K
5
AGN
Allergan plc
AGN
+$289K

Sector Composition

Rank Sector Weight
1 Financials 23.09%
2 Energy 18.96%
3 Healthcare 15.54%
4 Consumer Discretionary 10.93%
5 Industrials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVR icon
1
NVR
NVR
$17.2B
$3.41M 4.06%
1,233
-67
-5% -$176K
TBBK icon
2
The Bancorp
TBBK
$2.79B
$2.33M 2.77%
288,081
-16,125
-5% -$139K
CVX icon
3
Chevron
CVX
$388B
$2.22M 2.64%
18,043
+818
+5% +$96.8K
CATC
4
DELISTED
CAMBRIDGE BANCORP
CATC
$2.13M 2.54%
25,744
-1,013
-4% -$80.9K
MRK icon
5
Merck
MRK
$324B
$2.13M 2.53%
26,778
-3,144
-11% -$235K
PFE icon
6
Pfizer
PFE
$140B
$1.99M 2.36%
49,321
-604
-1% -$24.2K
PXD
7
DELISTED
Pioneer Natural Resource Co.
PXD
$1.99M 2.36%
13,051
+740
+6% +$104K
IBM icon
8
IBM
IBM
$202B
$1.98M 2.35%
14,674
+430
+3% +$54.8K
NBL
9
DELISTED
Noble Energy, Inc.
NBL
$1.9M 2.26%
76,779
-3,454
-4% -$78.2K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.73M 2.05%
8,597
+35
+0.4% +$7.07K
ABBV icon
11
AbbVie
ABBV
$458B
$1.72M 2.05%
21,374
+398
+2% +$32.6K
EOG icon
12
EOG Resources
EOG
$78B
$1.65M 1.97%
17,381
+645
+4% +$61.5K
LEN icon
13
Lennar Class A
LEN
$20.4B
$1.63M 1.94%
34,311
-336
-1% -$15.2K
BMY icon
14
Bristol-Myers Squibb
BMY
$127B
$1.6M 1.9%
33,443
-285
-0.8% -$14.2K
GILD icon
15
Gilead Sciences
GILD
$161B
$1.58M 1.88%
24,356
-96
-0.4% -$6.38K
HON icon
16
Honeywell
HON
$77.1B
$1.55M 1.84%
10,326
-513
-5% -$71.7K
WAL icon
17
Western Alliance Bancorporation
WAL
$9.07B
$1.38M 1.64%
33,582
WRK
18
DELISTED
WestRock Company
WRK
$1.34M 1.59%
34,890
+12,475
+56% +$488K
XOM icon
19
ExxonMobil
XOM
$651B
$1.31M 1.56%
16,195
+885
+6% +$67.5K
LLY icon
20
Eli Lilly
LLY
$1.07T
$1.28M 1.52%
9,831
-2,714
-22% -$330K
GIS icon
21
General Mills
GIS
$19.2B
$1.22M 1.45%
23,580
+1,520
+7% +$68.8K
WFC icon
22
Wells Fargo
WFC
$261B
$1.19M 1.42%
24,688
-1,330
-5% -$65.4K
CF icon
23
CF Industries
CF
$19.2B
$1.18M 1.41%
28,974
-333
-1% -$14.1K
JPM icon
24
JPMorgan Chase
JPM
$939B
$1.11M 1.33%
11,010
+225
+2% +$23.2K
DIS icon
25
Walt Disney
DIS
$165B
$1.03M 1.23%
9,297
+429
+5% +$48K

Similar funds

Sippican Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Sippican Capital Advisors held 112 positions worth $84.1M, up 14% from $74M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sippican Capital Advisors deployed $2.92M of net new capital in Q1 2019, opening 9 new positions and adding to 47 existing holdings. Its largest new stake was Weyerhaeuser: 17,460 shares worth $460K.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Synovus, an estimated $338K trimmed.

  • Sippican Capital Advisors's largest Q1 2019 buy was Weyerhaeuser: 17,460 shares worth $460K.
  • Sippican Capital Advisors added most to WestRock Company in Q1 2019, an estimated $488K increase.
  • Sippican Capital Advisors's biggest Q1 2019 reduction was Synovus, cutting an estimated $338K.
  • Sippican Capital Advisors fully exited Celgene Corp in Q1 2019, selling an estimated $318K.
  • Sippican Capital Advisors's ten largest holdings make up 26% of its $84.1M portfolio in Q1 2019.
  • Sippican Capital Advisors opened 9 new positions and closed 2 in Q1 2019.
  • Sippican Capital Advisors's portfolio value rose 14% quarter-over-quarter to $84.1M.

Based on Sippican Capital Advisors's 13F filing for Q1 2019, filed 17 Apr 2019.